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Host lipids have been implicated in the pathogenesis of Toxoplasma gondii infection. To determine if Toxoplasma 
infection influences the lipid status in the normal host, we assessed serum lipids of Swiss-Webster mice during infec-
tion with the BGD-1 strain (type-2) at a series of time points. Mice were bled at days zero and 42 post-infection, and 
subgroups were additionally bled on alternating weeks (model 1), or sacrificed at days zero, 14 and 42 (model 2) 
for the measurement of total cholesterol (Chl), high density lipoproteins (HDL), low density lipoproteins (LDL) and 
triglycerides and adiponectin. At day 42, brains were harvested for cyst enumeration. A significant decrease (p = 
0.02) in HDL and total Chl was first noted in infected vs. control mice at day 14 and persisted to day 42 (p = 0.013). 
Conversely, LDL was unaltered until day 42, when it increased (p = 0.043). Serum LDL levels at day 42 correlated 
only with cyst counts of above 300 (found in 44% mice), while the change in HDL between days zero and 42 corre-
lated with both the overall mean cyst count (p = 0.041) and cyst counts above 300 (p = 0.044). Calculated per cyst, 
this decrease in HDL in individual animals ranged from 0.1-17 µmol/L, with a mean of 2.43 ± 4.14 µmol/L. Serum 
adiponectin levels remained similar between infected and control mice throughout the experiment. 
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There is an emerging body of evidence showing that 
the intracellular protozoan Toxoplasma gondii alters 
host cell metabolism for entry and replication and uses 
host metabolic products for its own metabolic pathways. 
Toxoplasma cannot synthesize cholesterol (Chl) de novo 
and depends upon acquisition of low density lipoprotein 
(LDL)-derived Chl from the host cell, via endocytosis 
mediated by the LDL receptor (Coppens et al. 2000) or 
the LDL receptor-related protein (Portugal et al. 2008). A 
mechanism by which host and not parasite Chl controls the 
entry of Toxoplasma into cells has been proposed (Cop-
pens & Joiner 2003). These studies indicate that Chl does 
have an important role in pathogenesis of toxoplasmosis. 
However, data on parasite lipid sources are scarce and the 
molecular mechanisms by which Toxoplasma acquires 
host cell lipids are largely unknown (Coppens 2006). 
To determine if Toxoplasma infection influences the 
host lipid status in vivo, serum lipid levels were assessed at 
different time points during infection in wild-type mice.
MATERIAL AND METHODS
 Mice - Female Swiss-Webster mice (Medical Mili-
tary Academy Animal Research Facility, Belgrade) 
weighing 18-20 g at the beginning of each experiment, 
were used. Mice were housed at six per cage and offered 
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regular mouse feed and drinking water ad libitum. The 
study protocol was approved by the Institute for Medical 
Research Ethics Committee.
Parasites - The low virulence BGD-1 strain (human 
origin type-2 strain) characterized in our laboratory 
(Djurković-Djaković et al. 2006) was used for experi-
mental infections. Mice were inoculated by oropharyn-
geal gavage with eight cysts, an inoculum shown to be 
non lethal for > 90% of the mice during the first eight 
weeks post-infection (p.i.). 
Experimental design - Two different experimental 
models were used. To examine the kinetics of the lipids 
at an individual level during Toxoplasma infection (mod-
el 1), animals were infected (n = 54) or left uninfected 
(n = 18) to serve as controls. Both groups were bled at 
days zero and 42 p.i. and subgroups of 6-12 mice were 
bled on alternating weeks at days 7, 14, 21 and 28, for 
the measurement of total Chl, high density lipoprotein 
(HDL), LDL and triglyceride levels. At day 42 p.i., mice 
were euthanized and their brains were harvested for cyst 
enumeration. The experiment was performed twice and 
the data shown are their cumulative results. 
Model 2 was designed to correlate blood lipid levels 
with adiponectin as well as with local changes in tis-
sues. Groups of infected (n ≥ 9) and control (n = 6) mice 
were euthanized at days zero, 14 and 42 p.i. and blood 
was drawn for the measurement of lipids as above and of 
adiponectin. Brains and livers were harvested for future 
tissue and molecular analyses.
 
Lipids - Total Chl, HDL, LDL and triglycerides were 
measured on the Olympus AU 400 biochemical analyzer, 
according to the manufacturer’s recommendations.
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Adiponectin - Adiponectin levels were determined 
using a sandwich enzyme immunoassay test kit (Quan-
tikine Mouse Adiponectin/Acrp30 Immunoassay, R&D 
Systems, Abingdon, UK) according to the manufac-
turer’s instructions. The optical density was read on a 
Multiscan (Labsystems, Helsinki, Finland) microplate 
reader. The assay was performed in duplicate and mean 
values were calculated using a standard curve as de-
scribed by the manufacturer. The sensitivity threshold 
was 0.003 ng/mL. 
Cyst enumeration - Immediately after euthanasia, 
brains were harvested and homogenized in PBS. For cyst 
enumeration, 25 μL of the brain suspensions was placed 
on slides and cysts were counted under a phase-contrast 
microscope (Axioskop 2 Plus Zeiss). The number of 
cysts per brain was calculated by multiplying the num-
ber counted in four drops (by 3 experienced investiga-
tors) by 10, giving a sensitivity threshold for our method 
of 10 cysts per brain. 
Statistics - All statistical analyses were performed 
using the SPSS (version 10.0) package (SPSS Inc, Chi-
cago, IL, USA). Differences between Chl fraction means 
within particular groups at different time points were 
evaluated by ANOVA, followed by Fischer’s LSD test, 
while differences in Chl fraction means and adiponectin 
levels between infected and control group means were 
analyzed by the Student t-test or the Mann-Whitney test, 
Fig. 1: kinetics of serum lipid levels (mean ± SD) during the course of Toxoplasma infection in Swiss Webster mice induced with eight cysts of the 
BGD-1 strain. Groups of mice (n = 6-12) bled at alternative weeks and euthanized at day 42 (n = 54). A: total cholesterol (Chl) in infected (Chl inf) 
and control (Chl con) mice; B: high density lipoprotein (HDL) in infected (HDL inf) and control (HDL con); C: low density lipoprotein (LDL) in 
infected (LDL inf) and control (LDL con); D: triglycerides (Trig) in infected (Trig inf) and control (Trig con). Asterisk: p < 0.05 vs. control mice.
as appropriate. Correlation between cyst number and Chl 
fractions was determined by Spearman’s rank coefficient 
and correlation between cyst number and change in Chl 
fractions from day zero to day 42 (Δ) by two-tailed Pear-
son’s coefficient. The level of significance was 0.05.
RESULTS
The kinetics of serum lipids in mice during Toxo-
plasma infection is presented in Fig. 1. No difference be-
tween infected and control animals was seen at day 7 p.i.; 
however, at day 14, the mean Chl level decreased sharply 
(p = 0.019) and although slightly increasing thereafter, 
remained significantly (p = 0.045) decreased at day 42 
as compared to control levels (Fig. 1A). This decrease in 
Chl was reflected in the same kinetics in HDL levels; 
i.e. abrupt decrease at day 14 (p = 0.02) and lower HDL 
levels at day 42 as compared to controls (p = 0.013) (Fig. 
1B). Conversely, LDL levels were comparable between 
infected and control animals by day 28, including an un-
expected rise at day 21 vs. previous time points (Fig. 1C). 
Only at day 42 was a small, albeit significant (p = 0.043) 
increase in LDL observed in infected animals. Some 
changes in triglyceride levels were observed during the 
experiment, but were seen in both infected and control 
mice and thus resulted in no significant alterations at any 
time point (Fig. 1D).
The cyst numbers recovered at day 42 varied greatly 
(mean ± SD = 916 ± 1677, range 20-7460 per brain); how-
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ever, notably, only three animals had cyst counts above 
2,500. Correlation analyses of the cyst counts at different 
levels with all lipid fractions (Fig. 2) revealed only one 
significant result - a positive correlation (Spearman’s r = 
0.517, p = 0.023) between cyst counts above 300 (found 
in 44% mice) and LDL level. More importantly, however, 
when the cyst counts in individual animals were corre-
lated with the change in Chl fractions from d0-d42 (Δ), 
a positive correlation (Pearson) was obtained between Δ 
HDL and both the overall mean cyst count (r2 = 1, p = 
0.041) (Fig. 3A) and cyst count above 300 (r2 = 0.22, p = 
0.044) (Fig. 3B). The decrease in the level of HDL per cyst 
in individual animals ranged from 0.1-17 µmol/L (possi-
bly reflecting variation in cyst size and/or content), with 
a mean of 2.43 ± 4.14 µmol/L. No correlations between Δ 
LDL and either overall cyst count (r2 = 0.05, p = 0.162) or 
cyst count above 300 (r2 = 0.17, p = 0.081) were found. 
In model 2, lipid levels in infected vs. control mice 
showed a trend similar to that in model 1, i.e., a decrease 
in HDL at day 14 and comparable levels of triglycerides, 
but the increase in LDL noted at day 42 did not reach sig-
nificance (due to a lower number of animals per group 
and hence a lower statistical power). No significant dif-
ferences in adiponectin levels were found between in-
fected and control groups at either days 14 or 42. 
DISCUSSION
Chl metabolism in mammalian cells involves direct 
transport of preformed sterol from the liver to the periph-
ery, in the form of VLDL and LDL. On the other hand, 
tissue Chl is transported from peripheral cells through 
the plasma compartment back to the liver in the form of 
HDL (Fielding & Fielding 1995). 
The major lipid metabolism alterations obtained in a 
model of experimental toxoplasmosis in normal mice in-
cluded a decrease in serum HDL and, accordingly, in to-
tal Chl, beginning at day 14 p.i. and continuing until the 
end of the experiment at day 42; an increase in LDL only 
at this latter time point; and no alterations in triglyceride 
Fig. 2: correlation between serum lipid levels by fraction and Toxo-
plasma brain cyst counts above 300 harvested at day 42 post-infection 
(Spearman’s rank coefficient).
Fig. 3: correlation between changes from day 0-42 serum high den-
sity lipoprotein (HDL) in individual mice (Δ HDL) and total counts 
(A) and counts above 300 (B) of Toxoplasma brain cysts harvested at 
day 42 post-infection (Pearson’s correlation coefficient).
levels at any time point. Furthermore, the cyst counts pos-
itively correlated with the change between pre-infection 
and day 42 HDL levels, while only higher (> 300) cyst 
counts correlated with day 42 serum LDL levels.  
Lipid metabolism in parasitic infections is poorly un-
derstood. Data from experimental models are mainly de-
rived from studies addressing the issue of the atherogen-
ic potential of parasitic infection. Normal mice infected 
with Trypanosoma cruzi and Schistosoma mansoni were 
found to have decreased levels of total blood Chl. How-
ever, in the trypanosome infection model, Chl fractions 
have not been analyzed (Sunnemark et al. 2000). On the 
other hand, while S. mansoni is a trematode completely 
unrelated to Toxoplasma, schistosomes do not synthesize 
Chl, but incorporate host LDL via inducible LDL recep-
tors. In S. mansoni infected outbred mice, a reduction 
in total Chl and HDL and an insignificant rise in LDL 
was shown at a time at which infection became patent 
(Doenhoff et al. 2002). This is quite similar to what we 
showed in our model of Toxoplasma infection. However, 
our results are difficult to compare with previous work, 
since the only available data are obtained from studies 
in spontaneously atherosclerotic mice. In two models of 
genetically modified mice, i.e. ApoE deficient mice with 
consequently high VLDL and total Chl levels (four-fold 
higher than in normal mice as calculated with a conver-
sion coefficient 0.0259 for mg/dL to mmol/L) and LDL 
receptor deficient mice (LDLr-/-) who have high lev-
els of LDL and total Chl, Portugal et al. (2004, 2008) 
showed that infection with cysts of the Me49 strain (a 
typical type-2 strain) induced a decrease in total Chl and 
VLDL levels, while HDL levels remained unaltered. In 
the LDLr-/- mice, there was also a decrease in the LDL 
levels. The observed decrease in the initially high levels 
of VLDL and LDL was attributed to acquisition by Toxo-
plasma. This is logical, as LDL is the major lipoprotein 
from which Toxoplasma takes Chl (Coppens et al. 2000). 
However, in our model of Toxoplasma infection in nor-
mal mice we did not see a decrease in LDL levels. To 
the contrary, serum LDL levels were increased at day 
42, i.e., at a time of established chronic infection. To in-
tegrate our results with the above data, it should first be 
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noted that, unlike ApoE- and LDLr-/- mice, normal mice 
have low serum LDL (Khovidhunkit et al. 2004) and 
high serum HDL (Lee & Choudhury 2007) levels. Thus, 
it may be postulated that upon infection with Toxoplas-
ma, uptake of Chl from serum LDL by proliferating par-
asites triggers mobilization of Chl from the liver to the 
periphery. Due to the use of Chl in peripheral tissues by 
Toxoplasma, less remains to be returned to the liver and 
thus decreased serum HDL is observed. The decrease at 
day 14 (but not at day 7) coincides with the time when 
the parasite burden has increased sufficiently to require 
significant LDL acquisition, measurable (in a host with 
low LDL and high HDL) only by HDL decrease. More-
over, the lower levels of Chl returned to the liver in the 
form of HDL are further explained by the correlation 
between cyst counts and changes from the baseline to 
the day 42 levels of HDL. Similarly, the significance of 
LDL as a Chl source for Toxoplasma is emphasized by 
the correlation between higher brain cyst burdens and 
increased day 42 serum LDL levels, reflecting increased 
mobilization of Chl from the liver.
Another reason for decreased HDL may be the acute 
phase response, which is an immediate reaction, associ-
ated with hypertriglyceridemia. However, since the de-
crease in HDL levels in our model did not occur until 
day 14, and persisted up to day 42 with no changes in 
triglycerides, the lipid alterations observed do not seem 
to be part of the acute phase response. 
In our model, lipid alterations were not mediated by 
adiponectin. Adiponectin is a fat tissue hormone involved 
in lipid and carbohydrate metabolism, the circulating 
levels of which, under physiological conditions, posi-
tively correlate with plasma HDL concentrations (Cnop 
et al. 2003, Tschritter et al. 2003). We found no change in 
plasma adiponectin levels in infected animals, indicat-
ing no mediation by adiponectin of the HDL alterations 
observed. Hence, it appears that Toxoplasma induces se-
rum lipoprotein changes by influence on lipid receptors 
and apolipoproteins. To clarify the mechanisms of lipid 
metabolism alterations during experimental toxoplas-
mosis, we are currently looking into Chl receptors and 
transport proteins at the tissue and molecular level.
The use of outbred animals in our study may have 
accounted for the great variation in cyst burden as well 
as for the variation in some lipid fractions among indi-
vidual animals. An advantage of such a model, however, 
is that it examines lipid metabolism during the natural 
course of infection in the wild-type murine host. The 
lipid alterations observed despite individual variations 
only emphasize the burden of Toxoplasma infection on 
host lipid homeostasis, and homeostasis in general.
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